Author
Listed:
- Hannele Erkko
(Department of Clinical Genetics,)
- Bing Xia
(Dana-Farber Cancer Institute and Harvard Medical School, 44 Binney Street, Boston, Massachusetts 02115, USA)
- Jenni Nikkilä
(Department of Clinical Genetics,)
- Johanna Schleutker
(Laboratory of Cancer Genetics, Institute of Medical Technology, FIN-33520 University of Tampere and Tampere University Hospital, Finland)
- Kirsi Syrjäkoski
(Laboratory of Cancer Genetics, Institute of Medical Technology, FIN-33520 University of Tampere and Tampere University Hospital, Finland)
- Arto Mannermaa
(Institute of Clinical Medicine, Pathology and Forensic Medicine, Kuopio University Hospital, FIN-70211 Kuopio, Finland)
- Anne Kallioniemi
(Laboratory of Cancer Genetics, Institute of Medical Technology, FIN-33520 University of Tampere and Tampere University Hospital, Finland)
- Katri Pylkäs
(Department of Clinical Genetics,)
- Sanna-Maria Karppinen
(Department of Clinical Genetics,)
- Katrin Rapakko
(Department of Clinical Genetics,)
- Alexander Miron
(Dana-Farber Cancer Institute and Harvard Medical School, 44 Binney Street, Boston, Massachusetts 02115, USA)
- Qing Sheng
(Dana-Farber Cancer Institute and Harvard Medical School, 44 Binney Street, Boston, Massachusetts 02115, USA)
- Guilan Li
(Dana-Farber Cancer Institute and Harvard Medical School, 44 Binney Street, Boston, Massachusetts 02115, USA)
- Henna Mattila
(Laboratory of Cancer Genetics, Institute of Medical Technology, FIN-33520 University of Tampere and Tampere University Hospital, Finland)
- Daphne W. Bell
(Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129, USA
Present address: National Human Genome Research Institute/NIH, Bethesda, Maryland 20892, USA.)
- Daniel A. Haber
(Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts 02129, USA)
- Mervi Grip
(Department of Surgery,)
- Mervi Reiman
(Department of Clinical Genetics,)
- Arja Jukkola-Vuorinen
(Department of Oncology,)
- Aki Mustonen
(Department of Clinical Genetics,)
- Juha Kere
(University of Helsinki and Biomedicum Helsinki, FIN-00014 HY, Finland
and Clinical Research Centre, Karolinska Institutet, SE-17177 Huddinge, Sweden)
- Lauri A. Aaltonen
(University of Helsinki and Biomedicum Helsinki, FIN-00014 HY, Finland)
- Veli-Matti Kosma
(Institute of Clinical Medicine, Pathology and Forensic Medicine, Kuopio University Hospital, FIN-70211 Kuopio, Finland)
- Vesa Kataja
(Institute of Clinical Medicine, Oncology, Kuopio University Hospital, FIN-70211 Kuopio, Finland)
- Ylermi Soini
(University of Oulu and Oulu University Hospital, FIN-90029 OYS, Finland)
- Ronny I. Drapkin
(Dana-Farber Cancer Institute and Harvard Medical School, 44 Binney Street, Boston, Massachusetts 02115, USA)
- David M. Livingston
(Dana-Farber Cancer Institute and Harvard Medical School, 44 Binney Street, Boston, Massachusetts 02115, USA)
- Robert Winqvist
(Department of Clinical Genetics,)
Abstract
Breast cancer BRCA1, BRCA2 and other established susceptibility genes account for less than half of the known hereditary predisposition to breast cancer. So there are other relevant genes to be discovered. A new study in a Finnish population has identified a recurrent mutation in the PALB2 gene that is associated with increased breast cancer risk. PALB2 acts with BRCA2 in DNA repair, and the newly identified mutations impair this function.
Suggested Citation
Hannele Erkko & Bing Xia & Jenni Nikkilä & Johanna Schleutker & Kirsi Syrjäkoski & Arto Mannermaa & Anne Kallioniemi & Katri Pylkäs & Sanna-Maria Karppinen & Katrin Rapakko & Alexander Miron & Qing Sh, 2007.
"A recurrent mutation in PALB2 in Finnish cancer families,"
Nature, Nature, vol. 446(7133), pages 316-319, March.
Handle:
RePEc:nat:nature:v:446:y:2007:i:7133:d:10.1038_nature05609
DOI: 10.1038/nature05609
Download full text from publisher
As the access to this document is restricted, you may want to
for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:446:y:2007:i:7133:d:10.1038_nature05609. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.